MARKET

TECH

TECH

Bio-Techne
NASDAQ

Real-time Quotes | Nasdaq Last Sale

272.40
-4.97
-1.79%
After Hours: 272.40 0 0.00% 16:00 07/10 EDT
OPEN
278.20
PREV CLOSE
277.37
HIGH
278.53
LOW
271.54
VOLUME
135.90K
TURNOVER
--
52 WEEK HIGH
282.52
52 WEEK LOW
155.17
MARKET CAP
10.41B
P/E (TTM)
57.52
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TECH stock price target is 253.38 with a high estimate of 320.00 and a low estimate of 211.00.

EPS

TECH News

More
NTG Clarity Networks reports Q1 results
NTG Clarity Networks (OTCPK:NYWKF): Q1 GAAP EPS of -$0.01. Revenue of $2.47M (-31.6% Y/Y) Press Release
seekingalpha · 1d ago
Amazon and Netflix pitched on buying a theater chain
Bank of America revisits the idea of Amazon (NASDAQ:AMZN) or Netflix (NASDAQ:NFLX) acquiring a movie theater and builds a case for why it makes sense in th
seekingalpha · 1d ago
PTC preliminary FQ3 ARR up 10%
PTC (NASDAQ:PTC) announces preliminary fiscal Q3 ARR growth of 9% Y/Y, or 10% in constant currency. The company expects double-digit revenue and FCF growth
seekingalpha · 1d ago
CynergisTek +44% secures renewal contracts worth $0.95M
CynergisTek (NYSEMKT:CTEK) +44% announced renewals of two perennial fortune 1000 and global 500 clients for information technology audit and compliance con
seekingalpha · 1d ago
EXFO EPS of $0.06
EXFO (NASDAQ:EXFO): Q3 EPS of $0.06 may not be comparable to consensus of -$0.03. Revenue of $66.15M (-10.1% Y/Y) beats by $6.56M. Press Release
seekingalpha · 1d ago
EA announces reality show based on 'The Sims'
Electronic Arts (NASDAQ:EA) partners with Turner Sports' ELEAGUE on a four-part reality television series based on The Sims game franchise. The Sims Spark'
seekingalpha · 1d ago
Twitter subscription tier 'highly unlikely' - Rosenblatt
Rosenblatt analyst Mark Zgutowicz thinks Twitter (TWTR +8.0%) is "highly unlikely" to launch a subscription tier for general users. A data analytics tier f
seekingalpha · 1d ago
Google shelves cloud project for China - Bloomberg
Bloomberg sources say Google (GOOG,GOOGL) scrapped plans for a new major cloud service in China on concerns over political tensions and the coronavirus pan
seekingalpha · 1d ago

Industry

Biotechnology & Medical Research
-0.77%
Pharmaceuticals & Medical Research
-0.48%

Hot Stocks

Symbol
Price
%Change

About TECH

Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis. The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market.
More

Webull offers kinds of BIO-TECHNE Corp stock information, including NASDAQ:TECH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TECH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TECH stock methods without spending real money on the virtual paper trading platform.